Evidence map›Paper›PMID 34317383›Full record

ArticleJACC. Case reports2020

Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome: Protecting Families.

Maria Grazia De Gregorio, Francesca Girolami, Benedetta Tomberli, Guendalina Rossi, Alessia Tomberli, Katia Baldini, Iacopo Olivotto

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. A Novel Variant in theClinical, cosmetic and investigational dermatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maria Grazia De GregorioCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Francesca GirolamiCardiology Unit, Meyer University Hospital, Florence, Italy.
Benedetta TomberliCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Guendalina RossiCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Alessia TomberliCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Katia BaldiniCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Iacopo OlivottoCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a 37-year-old cardiac arrest survivor with autosomal dominant Carvajal syndrome and arrhythmogenic cardiomyopathy, a desmoplakin mutation was identified. Cascade screening identified 2 affected family members and 2 healthy children carrying the mutation. Strategies for primary and secondary risk prevention emphasize the role of genetic testing in rare cardiomyopathies. (

Indexed as

AC, arrhythmogenic cardiomyopathyarrhythmic riskCarvajal syndromecascade screeningdesmoplakinECG, electrocardiogramgenetic testingLV, left ventricularRV, right ventricularsudden cardiac death

Identifiers

PMID34317383
PMCPMC8302052
OpenAlexW3036493711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.